BTK inhibitors (Fudan university/Shanghai Institute of Pharmaceutical Industry/China State Institute of Pharmaceutical Industry)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameBTK inhibitors (Fudan university/Shanghai Institute of Pharmaceutical Industry/China State Institute of Pharmaceutical Industry)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase BTK inhibitors
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesFudan University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFudan UniversityChina State Institute of Pharmaceutical Industry Co LtdState Pharmaceutical Administration of Shanghai Institute of Pharmaceutical Industry
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A